Home Ingredients Longvida® Optimized Curcumin (Verdure Sciences)
CognitiveAnti-Inflammatory

Longvida® Optimized Curcumin (Verdure Sciences)

Curcuma longa
Evidence Level
Moderate
3 Clinical Trials
7 Documented Benefits
3/5 Evidence Score

Longvida® is a patented curcumin extract developed by Verdure Sciences using SLCP™ (Solid Lipid Curcumin Particle) technology designed by UCLA neuroscientists. Distinguished by ability to deliver free (UNGLUCURONIDATED) curcumin to brain and target tissues — bypasses initial hydrolysis. In a small pharmacokinetic study it delivered free (unconjugated) curcumin where equal-dose unformulated curcumin was undetectable in plasma. Brand-specific human clinical evidence is limited (a pharmacokinetic study, two small cognition/mood RCTs from one research group, and one exercise-recovery biomarker trial). Marketed as 'The Cognitive Curcumin of Choice®'. Studied in small trials for cognitive function and mood and for exercise-recovery muscle-damage biomarkers; retinal health is preliminary. Joint health, oxidative stress, and immune support are marketing categories not established by Longvida-specific human trials.

Studied Dose 400 mg/day (cognitive); 800 mg/day (joint health, exercise recovery); range 400-2,000 mg/day per application.
Active Compound Curcumin in a Solid Lipid Curcumin Particle (SLCP) formulation.

Benefits

Cognitive Function (400 mg/day)

Two small placebo-controlled RCTs from the same research group (Cox 2015, n=60; Cox 2020, n=80, a partial replication) in healthy older adults reported improvements in working memory and mood at 400 mg/day, with some acute effects within 1 hour. This preliminary evidence has not been independently replicated. Formulation designed by UCLA neuroscientists for brain delivery.

Supported by Trial 3, Trial 2

Improved Free-Curcumin Bioavailability (Pharmacokinetic Study)

A small pharmacokinetic study (Gota 2010, n=11 osteosarcoma patients plus healthy volunteers) detected free (unconjugated) curcumin after Longvida whereas an equal dose of unformulated curcumin was undetectable in plasma; the '65x' figure is a marketing bioavailability claim, and bioavailability is a pharmacokinetic measure rather than proof of clinical benefit. A major distinction, since most curcumin in the body is glucuronidated (inactive) within hours; Longvida delivers free curcumin via the lymphatic system.

Supported by Trial 1

Free Curcumin in Bloodstream Within 1 Hour

A pharmacokinetic study demonstrated free curcumin in the bloodstream within 1 hour of Longvida ingestion; supports once-daily dosing with sustained metabolite presence over 24 hours.

Supported by Trial 1, Trial 3

Joint Health and Exercise Recovery (800 mg/day)

The one Longvida exercise study (McFarlin 2016, 400 mg/day) measured muscle-damage and inflammatory biomarkers (CK, TNF-alpha, IL-8) after exercise-induced muscle damage; it did not assess joints or osteoarthritis and did not change subjective soreness. No Longvida-specific joint or osteoarthritis trial supports a joint-health claim.

Supported by Trial 1, Trial 2

Healthy Cognitive Aging

Particularly relevant for healthy adults wanting cognitive support during aging; complements Bacopin/BaCognize and other cognitive ingredients.

Supported by Trial 2, Trial 3

Tau Oligomer Effects (Mechanism Research)

Animal research suggests Longvida affects soluble tau oligomers in tau transgenic mice — a mechanistic finding only; it has not been demonstrated in humans and is not a claim to treat or prevent any neurodegenerative disease.

Supported by Trial 1, Trial 2

Retinal Health Support

Preliminary, largely preclinical evidence suggests Longvida may reach retinal tissue; a retinal benefit in humans is not established.

Supported by Trial 1, Trial 2

Mechanism of action

1

Solid Lipid Curcumin Particle (SLCP) Technology

Patented SLCP technology dissolves at point of GI absorption; helps free curcumin cross into bloodstream; bypasses first-pass metabolism; delivers via lymphatic system; designed by UCLA neuroscientists.

2

Free vs Glucuronidated Curcumin

Standard curcumin is rapidly glucuronidated (conjugated) in liver — converts to inactive metabolites; Longvida delivers free (unconjugated) curcumin which is the bioactive form.

3

Blood-Brain Barrier Crossing

Longvida designed to cross blood-brain barrier — supports cognitive applications; distinguishes from many curcumin products.

4

NF-kB and COX-2 Inhibition

Same fundamental anti-inflammatory mechanism as other curcumin; Longvida's bioavailability advantage delivers more active to inflammation sites including brain.

5

Multiple Pathways

Curcumin pleiotropic effects on inflammation, oxidative stress, mitochondrial function, neurotrophic factors.

Clinical trials

1
Longvida Bioavailability

Pharmacokinetic study comparing Longvida vs unformulated curcumin.

Healthy adults.

A pharmacokinetic study detected free (unconjugated) curcumin after Longvida whereas an equal dose of unformulated curcumin was undetectable; the '65x' figure is a marketing claim and bioavailability is not proof of clinical benefit.

2
Longvida Cognitive Function

Clinical trial of Longvida 400 mg/day in healthy middle-aged adults.

Healthy middle-aged adults.

Multiple beneficial effects on cognitive and biological markers.

3
Acute Cognitive Effects of Longvida

Studies of Longvida acute cognitive effects within 1 hour.

Healthy adults.

Cognitive performance improvements within 1 hour of supplementation; effect not typical of curcumin products.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated.
Mild GI distress (rare).
Yellow staining (mouth, urine) — harmless.
Allergic reactions rare.
GRAS food additive ingredients in formulation.

Important Drug interactions

Anticoagulants — modest antiplatelet effects from curcumin.
Antiplatelets — additive bleeding risk.
Diabetes medications — modest hypoglycemic effects.
Pre-surgery — discontinue 1-2 weeks before.
Gallstones / bile duct obstruction — curcumin has cholagogue effects; avoid.
Pregnancy — culinary turmeric safe; concentrated supplementation limited safety data; avoid high-dose during pregnancy.
Lactation — culinary safe; supplementation limited data.
Iron absorption — modest reduction at high doses.
Hepatically-metabolized medications — modest CYP interactions.

Featured in these supplement guides

Eye Health→Inflammation→Liver Health→Mouth & Gum Health→Skin Health & Anti-Aging→

More Cognitive Ingredients

Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…
Cognitive
KSM-66®
KSM-66 is the most extensively studied branded ashwagandha (Withania somnifera) extract, m…
Cognitive
Alpha-GPC
Alpha-GPC (alpha-glycerophosphocholine) is a highly bioavailable source of choline that re…

Explore Other Ingredients

Hair, Skin & Nails
Hyaluronic Acid
Hyaluronic acid is a naturally occurring substance in the body, primarily found in connect…
Joint Health
Glucosamine
Glucosamine, a natural compound found in cartilage, is commonly supplemented as glucosamin…
Athletic Performance
L-Carnitine
L-Carnitine is a naturally-occurring amino acid derivative essential for fatty acid metabo…

Frequently asked questions about Longvida® Optimized Curcumin (Verdure Sciences)

What is Longvida Optimized Curcumin?

Longvida® is a patented curcumin extract developed by Verdure Sciences using SLCP™ (Solid Lipid Curcumin Particle) technology designed by UCLA neuroscientists. Distinguished by ability to deliver free (Unglucuronidated) curcumin to brain and target tissues — bypasses initial hydrolysis.

What is Longvida Optimized Curcumin used for?

Longvida Optimized Curcumin is researched primarily for Cognitive and Anti-Inflammatory. Two small placebo-controlled RCTs from the same research group (Cox 2015, n=60; Cox 2020, n=80, a partial replication) in healthy older adults reported improvements in working memory and mood at 400 mg/day, with some acute effects within 1…

What is the recommended dosage of Longvida Optimized Curcumin?

The clinically studied dose is 400 mg/day (cognitive); 800 mg/day (joint health, exercise recovery); range 400-2,000 mg/day per application. Always follow the product label and check with a healthcare provider for personal advice.

Is Longvida Optimized Curcumin safe, and does it have side effects?

For most healthy adults, Longvida Optimized Curcumin is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated. Mild GI distress (rare). It may also interact with some medications. Longvida Optimized Curcumin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Longvida Optimized Curcumin interact with any medications?

Possible interactions include: Anticoagulants — modest antiplatelet effects from curcumin. Antiplatelets — additive bleeding risk. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Longvida Optimized Curcumin?

NutraSmarts rates the evidence for Longvida Optimized Curcumin as Moderate (3 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem. 2010;58(4):2095-9. doi: 10.1021/jf9024807.PubMedUsed to support: Brand-specific (Longvida SLCP) PK study. Detected unconjugated free curcumin after 650 mg Longvida (peak ~22.4 ng/mL) whereas equal-dose unformulated 95% curcuminoids gave undetectable plasma curcumin. Small (11 osteosarcoma patients + healthy volunteers); industry-affiliated formulation.
  2. Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol. 2015;29(5):642-51. doi: 10.1177/0269881114552744.PubMedUsed to support: Brand-specific (400 mg Longvida) randomized, double-blind, placebo-controlled trial in 60 healthy adults 60-85. One hour post-dose improved sustained attention and working memory; 4 weeks improved working memory and mood vs placebo. Small sample.
  3. Cox KHM, White DJ, Pipingas A, Poorun K, Scholey A. Further evidence of benefits to mood and working memory from lipidated curcumin in healthy older people: a 12-week, double-blind, placebo-controlled, partial replication study. Nutrients. 2020;12(6):1678. doi: 10.3390/nu12061678.PubMedUsed to support: Brand-specific (400 mg/d Longvida) 12-week RCT in 80 healthy adults 50-80; partial replication. Improved working memory and lower fatigue at 12 weeks; reduced tension/anger/confusion at 4 weeks. Small sample.
  4. McFarlin BK, Venable AS, Henning AL, Sampson JNB, Pennel K, Vingren JL, Hill DW. Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin. BBA Clin. 2016;5:72-8. doi: 10.1016/j.bbacli.2016.02.003.PubMedUsed to support: Brand-specific (400 mg/d Longvida): after exercise-induced muscle damage, curcumin lowered CK (~48%), TNF-alpha (~25%), and IL-8 (~21%) vs placebo, with no change in IL-6/IL-10 or subjective soreness. Small sample.